Article Tools

Intercell Successfully Completes Vaccine Study in India

Published: September 16, 2011; 11:36 · (Vindobona)

The Austrian biotech company achieved an important step in the licensure process of a vaccine for children.

Intercell Successfully Completes Vaccine Study in India / Picture: © Intercell

Intercell AG and its partner Biological E. Ltd. today announced the successful completion of a pediatric Phase II/III study for the vaccine to protect children from Japanese Encephalitis (JE). Analysis of the pivotal Phase III safety and immunogenicity data showed positive results and that the study met its primary endpoint.

The study, conducted across eight study sites in India…

This article includes a total of 296 words.

or Log In